Form 4: Soleno Therapeutics CFO James Mackaness Reports Stock Sales and Option Exercises
SEC Form 4 Filing
James Mackaness, CFO of Soleno Therapeutics, reports the sale of common stock to cover tax obligations and the exercise of employee stock options.
Summary
- On March 27, 2025, James Mackaness, the CFO of Soleno Therapeutics, executed multiple transactions involving the company's common stock.
- Mackaness sold shares to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
- These sales were executed in multiple trades at varying prices, ranging from $65.15 to $72.80 per share.
- He also exercised employee stock options to acquire additional shares at prices ranging from $2.41 to $30.75.
- Following these transactions, Mackaness directly owns 175,176 shares of Soleno Therapeutics common stock and holds options to purchase additional shares.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors as they can provide insights into management's view of the company's prospects.
Stakeholder Impact
- The stock sales could have a minor dilutive effect on existing shareholders.
- The option exercises increase the number of shares outstanding.
Key Dates
| Date | Description |
|---|---|
| 01/01/2022 | Vesting Commencement Date for some employee stock options. |
| 02/01/2023 | Vesting date for some employee stock options. |
| 06/26/2023 | Vesting date for some employee stock options. |
| 03/27/2025 | Date of the reported transactions: stock sales and option exercises. |
| 03/31/2025 | Date of signature on the Form 4 filing. |
| 11/16/2030 | Expiration date for some employee stock options. |
| 01/28/2032 | Expiration date for some employee stock options. |
| 07/27/2032 | Expiration date for some employee stock options. |
| 01/25/2033 | Expiration date for some employee stock options. |
| 05/26/2033 | Expiration date for some employee stock options. |
Keywords
Form 4, Soleno Therapeutics, SLNO, James Mackaness, CFO, Stock Sale, Option Exercise, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.